MALERBA, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 1.062
NA - Nord America 1.005
AS - Asia 181
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 1
Totale 2.254
Nazione #
US - Stati Uniti d'America 1.002
IT - Italia 269
NL - Olanda 185
SE - Svezia 174
IE - Irlanda 159
CN - Cina 78
TR - Turchia 63
UA - Ucraina 63
DE - Germania 53
AT - Austria 49
GB - Regno Unito 38
FI - Finlandia 23
BE - Belgio 17
SG - Singapore 13
JP - Giappone 11
CH - Svizzera 10
IL - Israele 10
RU - Federazione Russa 7
ES - Italia 4
EU - Europa 4
FR - Francia 4
CA - Canada 2
CZ - Repubblica Ceca 2
IN - India 2
PK - Pakistan 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
HK - Hong Kong 1
KW - Kuwait 1
MX - Messico 1
PT - Portogallo 1
Totale 2.254
Città #
Chandler 218
Amsterdam 184
Dublin 159
Pisa 140
Jacksonville 128
Ann Arbor 87
New York 65
Izmir 62
Vienna 49
Wilmington 45
Ashburn 42
Boardman 40
Boston 29
Millbury 25
Mestre 24
Bremen 20
San Mateo 18
Woodbridge 17
Brussels 16
Falls Church 15
Lawrence 13
Ogden 12
Padova 11
Seattle 11
Tokyo 11
Washington 11
Rome 10
Singapore 10
Bern 9
Holon 9
Bientina 8
Princeton 8
Santa Clara 8
Scuola 8
Beijing 7
Guangzhou 6
Helsinki 6
Shanghai 6
Dearborn 5
Düsseldorf 5
Ferrara 5
Hefei 5
Los Angeles 5
Milan 5
Jiaxing 4
Las Vegas 4
Nanjing 4
Auburn Hills 3
Berlin 3
Fairfield 3
Frankfurt am Main 3
Houston 3
Paris 3
Saint Petersburg 3
Voghera 3
Wuhan 3
Bari 2
Edinburgh 2
Fuzhou 2
Genoa 2
Kunming 2
Lappeenranta 2
Nanchang 2
Prague 2
Rossano Veneto 2
San Giuliano Terme 2
Scarpizzolo 2
Stockholm 2
Tappahannock 2
Toronto 2
Trieste 2
Vetlanda 2
Wuxi 2
Antwerp 1
Baotou 1
Cambridge 1
Changsha 1
Chengdu 1
Chennai 1
Columbus 1
Copenhagen 1
Cusano Milanino 1
Dalian 1
Dallas 1
Dongyang 1
Florence 1
Forest City 1
Foshan 1
Hangzhou 1
Hanover 1
Heze 1
Istanbul 1
Jamaica Plain 1
Jinan 1
Jinhua 1
Kuwait City 1
Lahore 1
Lisbon 1
Livorno 1
Madrid 1
Totale 1.677
Nome #
A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists 217
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 160
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 143
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 137
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 128
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 121
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 117
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 116
The role of Nerve Growth Factor in development and in ALzheimer's disease 111
Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor 109
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 106
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 102
Involvement of NGF in early stages of chick embryo development 102
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 101
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization 100
NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward 91
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 91
ProNGF Is a Cell-Type-Specific Mitogen for Adult Hippocampal and for Induced Neural Stem Cells 88
proNGF/NGF mixtures induce gene expression changes in PC12 cells that neither singly produces 88
Targeting the cation-chloride co-transporter NKCC1 to re-establish GABAergic inhibition and an appropriate excitatory/inhibitory balance in selective neuronal circuits: a novel approach for the treatment of Alzheimer's disease 46
Nerve growth factor neutralization promotes oligodendrogenesis by increasing miR-219a-5p levels 40
Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia 18
Totale 2.332
Categoria #
all - tutte 9.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 0 0 3 4 21 6 40 13 20 7 19 1
2020/2021264 22 1 50 5 19 24 13 23 17 52 11 27
2021/2022204 12 1 3 12 22 12 7 14 20 13 12 76
2022/2023848 40 66 55 85 48 99 1 186 229 7 16 16
2023/2024313 32 6 25 5 22 91 15 4 24 15 4 70
2024/2025236 202 10 24 0 0 0 0 0 0 0 0 0
Totale 2.332